The Precious (Prevention of complications to improve outcome in elderly patients with acute stroke) research project, funded by the European Union’s Horizon 2020 research and innovation programme (grant agreement No 634809), ends at the end of November 2022.
The research began in June 2015 to find out if off-the-shelf treatments could reduce complications in older patients suffering from acute stroke and ultimately reduce lives lost to stroke and improve quality of life.
By the end of the clinical trial, almost 1500 stroke patients participated in the research across nine European countries. Researchers are now analysing the results which are hoping to be published in 2023.
Last year, SAFE interviewed Dr Bart van der Worp, UMC Utrecht, Netherlands, project coordinator about the research for Brain Awareness Week, read the interview here
Now, as the research closes, SAFE follows up with Bart for an update:
SAFE: What are you hoping the Precious research will show?
Bart: We hope that the analysis of the patient data will reveal answers to the following questions:
- If we are able to prevent infections and fever in the first four days after stroke with simple, safe, and inexpensive drugs, will this reduce the risk of death or dependency after stroke; improve quality of life; and reduce the length of hospital admission and healthcare costs?
- Does the prevention of vomiting with a simple and safe anti-emetic drug reduce the risk of pneumonia?
- Does the pain killer paracetamol also reduce blood pressure after stroke?
- Are there differences between countries in treatment restrictions after stroke, such as do-not-resuscitate orders, and do these restrictions increase the risk of death?
SAFE: When are you hoping to have the results of the trial?
Bart: The investigators across the nine participating countries are currently completing follow-up and collecting the most recent patient data. Analysis of the most important data will be completed by the end of this year, and we hope to present the main trial results at the European Stroke Organisation Conference in May 2023.
For more information visit https://www.precious-trial.eu/
We are pleased to announce that our first in person European Life After Stroke Forum is now open for registration and abstract submission.
The European Life After Stroke Forum, 10 March 2023, Barcelona, Spain, is the place to find the latest evidence and research in this neglected area of stroke care.
About the Forum
The Forum’s aim is to build the life after stroke healthcare, research and patient community, stimulate debate and build our collective knowledge in life after stroke.
Our ultimate goal is to improve the quality of life after stroke for the nine million people living with stroke in Europe.
Register before the end of the year to benefit from our early bird rates. Book your place here bit.ly/3UDIuli
Our forum programme covers a range of topical issues in life after stroke and will include keynote presentations by eminent speakers supplemented by contributed talks and a poster session.
See our initial programme at bit.ly/3GeAgvr
We are now seeking abstracts for the Forum, giving those interested an opportunity to present either a 10-minute oral presentation or a poster presentation.
We are looking for applications in two areas:
- Scientific applications: for completed or ongoing trials and studies in the broad area of life after stroke.
- Grab and Steal: to share experiences of service developments in life after stroke where these original ideas and innovative practices could be used by others.
You have until 10 January 2023 to submit your abstract and we look forward to receiving your submissions. Find out more bit.ly/3X0Je5x
Abstracts will be reviewed and all submissions will receive their notification letter by Friday 10 February 2023.
The Forum will be held at the Hotel Catalonia Barcelona Plaza. The hotel will offer delegate accommodation at €140 per night. To book, please email firstname.lastname@example.org and provide your name, your check-in and check-out dates, and mention the name of our event , ELASF2023.
Other accommodation can be found here
31 December Early bird rates end
10 January Deadline for abstract submission
10 February Abstract notification
Estonia has signed the Stroke Action Plan for Europe Declaration, committing to improving stroke services across the entire chain of care.
We congratulate them in taking a step towards the full implementation of the Stroke Action Plan For Europe.
Find out more at actionplan.eso-stroke.org/
Join a hybrid event on Addressing gender-related issues and bias in the prevention and treatment of neurological conditions that will take place on Tuesday, 29 November from 13:00 to 15:00 CET.
The event is hosted by the MEP Interest Group on Brain, Mind and Pain (BMP) – an initiative of the European Federation of Neurological Associations (EFNA) and Pain Alliance Europe (PAE).
Gender-related issues and bias can have a negative impact on women’s health including needs being overlooked, conditions being under-diagnosed/ misdiagnosed and delays in treatment.
Hosted in the European Parliament by MEP Sirpa Pietikäinen (EPP, FI), high-profile speakers, including healthcare professionals, patient representatives, policymakers and academics, will lead the discussions.
You can register here before 21 November 2022. Please note that due to the limited capacity of the room, participants will be accepted on a first come, first served basis. However, you can register here to access the event’s live-stream instead.
Not registered yet for the #LifeAfterStroke webinar tomorrow? Join all those who already signed up for this unique and popular free online event on Wednesday 9 November, from 10.00 CET. It’s not too late to join us and learn more about getting back to work, fatigue and physical activity after stroke.
Register at https://bit.ly/3BSVPQc
This event is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®). Delegates will be awarded three European CME credits (ECMEC®s) for attending all three sessions.
The ANGIE project aims to change the way we practice medicine by developing micro-robots for localised, targeted drug delivery to unblock blood vessels and fight stroke from within.
This ground-breaking project is funded by the EU and aims to develop nano-surgeons that will enter the body to treat blood clots.
Questions around issues related to communication, ethics, law, policy, and education will be discussed before the newly developed technology is released. This online event will discuss new market opportunities in the pharmaceutical industries.
Join the meeting via Zoom on 28 November 2022, 16.00 – 18.00 CET.